AMH is not a new test — it has been used in fertility medicine since the early 2000s. But its clinical applications have expanded significantly, and its role in IVF planning is now so fundamental that at ART Fertility Clinics, we consider it the cornerstone of every woman's fertility assessment.
If you are beginning to think about fertility treatment — or even just want to understand where your fertility stands right now — understanding AMH is where that knowledge starts.
What Is AMH?
Anti-Müllerian Hormone is a protein produced by the granulosa cells that surround the small, developing follicles in your ovaries. Each follicle contains one egg. The more follicles you have — the higher your ovarian reserve — the more AMH your ovaries produce.
This makes AMH a direct, measurable reflection of your egg supply at any given point in time.
Here is what makes AMH particularly valuable compared to other hormone tests:
It does not vary with your menstrual cycle. FSH, estradiol, and LH all fluctuate significantly through the month — they must be measured on specific cycle days. AMH remains stable throughout the cycle, meaning you can test on Day 1 or Day 20 and get the same result. This makes AMH far more practical for real-world use.
It declines predictably with age. AMH levels peak in the mid-20s and decline steadily through the 30s, reaching very low levels as menopause approaches. This age-related decline is gradual and predictable — which is what makes AMH useful as a fertility timeline tool.
It reflects the quantity of eggs, not quality. This distinction is important and often misunderstood. AMH tells you how many eggs you have — not how good they are. Egg quality is primarily determined by age. A 38-year-old with AMH of 2.5 ng/mL has more eggs than a 38-year-old with AMH of 0.6 ng/mL — but both women's eggs reflect the quality typical of a 38-year-old. This is why AMH must always be interpreted alongside age.
What Do AMH Numbers Mean?
AMH is measured in ng/mL (nanograms per millilitre) or pmol/L depending on the laboratory. The following ranges are commonly used in clinical practice — though interpretation always requires your age and clinical context:
Above 3.5 ng/mL — High ovarian reserve: Common in young women and those with PCOS. High AMH indicates many available follicles but also raises the risk of OHSS during IVF stimulation. Careful, low-dose protocols are essential.
1.0 – 3.5 ng/mL — Normal range: Appropriate reserve for reproductive age. Standard IVF protocols apply with good expected response.
0.5 – 1.0 ng/mL — Low-normal to low: Diminished ovarian reserve. IVF is still highly feasible, but higher medication doses may be needed and fewer eggs retrieved. Timing — starting IVF sooner rather than later — becomes more important.
0.1 – 0.5 ng/mL — Low: Significantly reduced reserve. IVF remains possible with specialised protocols. Some patients in this range achieve pregnancy; others may need multiple cycles or alternative approaches.
Below 0.1 ng/mL — Very low: Severely diminished reserve. Natural cycle IVF, mild stimulation, or donor egg IVF may be considered. A compassionate, detailed consultation is essential before any decisions are made.
These numbers are guides — not verdicts. We have seen women with AMH of 0.2 ng/mL conceive through IVF. We have seen women with AMH of 2.5 ng/mL need multiple cycles due to egg quality issues. AMH is one part of a complex picture.
How AMH Shapes Your IVF Treatment Plan
This is where AMH moves from interesting laboratory value to clinically actionable information. Here is exactly how your AMH result changes what happens in your IVF cycle:
Medication dosing: The starting dose of FSH injections used to stimulate your ovaries is directly informed by AMH. Women with low AMH typically require higher starting doses (225-300 IU/day) to recruit enough follicles. Women with high AMH (and especially PCOS) require low starting doses (75-100 IU/day) to prevent over-stimulation. Getting this dose right from the start reduces the risk of poor response or dangerous over-response.
Protocol selection: Low AMH patients may benefit from flare protocols or priming strategies that maximise follicle recruitment. High AMH patients need antagonist protocols with GnRH agonist triggers to protect against OHSS.
Trigger decision: In low AMH patients, hCG trigger is typically used to maximise egg maturity. In high AMH/PCOS patients, GnRH agonist trigger is preferred — dramatically reducing OHSS risk while maintaining maturity rates.
Cycle expectations: AMH helps your specialist have an honest conversation with you before you begin. A woman with AMH of 0.3 ng/mL needs to understand that she may retrieve 1-3 eggs — and that the plan may include accumulating embryos across multiple egg collections. A woman with AMH of 5.0 ng/mL needs to understand that a freeze-all strategy may be recommended to protect against OHSS. These conversations, grounded in real data, lead to better-prepared, less-surprised patients.
Timing advice: For women not yet trying to conceive who undergo AMH testing, a declining result over time can prompt earlier decision-making about family planning, egg freezing, or seeking treatment before reserve drops further.
AMH Testing in India — What You Should Know
AMH testing is widely available across India at major diagnostic labs (SRL, Metropolis, Dr Lal PathLabs) and at specialist fertility clinics. The test requires a simple blood draw with no fasting required and no specific cycle timing.
Cost ranges from ₹800 to ₹2,500 depending on the laboratory and location. At ART Fertility Clinics, AMH testing is included in our comprehensive fertility assessment package alongside AFC ultrasound, Day 3 hormones, and semen analysis — giving a complete picture in a single visit.
One important note on laboratory variation: AMH assays differ between laboratories, and results from different labs may not be directly comparable. If you are tracking AMH over time, try to use the same laboratory for consistency.
Conclusion
AMH is the most clinically useful single fertility marker available today — not because it predicts your destiny, but because it guides your plan. A low result is information, not a sentence. A high result is an asset that requires careful management. At ART Fertility Clinics, every patient's IVF journey begins with a complete ovarian reserve assessment including AMH — because personalised treatment starts with accurate data. If you have not had your AMH tested, or have a result you do not fully understand, speak with our specialists today.

